Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Recorded changes
82,244 on record
Recorded policy changes, newest first| Recorded | Payer | Policy | Change |
|---|
| Aug 22, 2026 | MetroPlusHealth | UM-MP251 Folic Acid TestingPayerPolicy · METROPLUS-UM-MP251 | Codes changed |
|---|
| Aug 22, 2026 | MetroPlusHealth | UM-MP230 Yescarta (Axicabtagene ciloleucel)PayerPolicy · METROPLUS-UM-MP230 | Codes changed |
|---|
| Aug 22, 2026 | MetroPlusHealth | UM-MP219 Kymriah (tisagenlecleucel)PayerPolicy · METROPLUS-UM-MP219 | Codes changed |
|---|
| Aug 22, 2026 | Kaiser Permanente Washington | Infliximab AntibodiesPayerPolicy · KAISER_WA-INFLIXIMAB-ANTIBODIES | Codes changed |
|---|
| Aug 22, 2026 | Kaiser Permanente Washington | Genicular Nerve Ablation GERD - Bulking Material, CR BARD's Suturing System, and Stretta Procedure GERD - Linx Reflux Management System Glanzmann's Disease Glaucoma Surgical Procedures Globus Pallidus & Subthalamic Nucleus Stimulator Implant Glucose Monitoring gMSDx and gMSPro EDSS Testing Gravlee Jet Washer Gynecomastia Hearing Aids Heart Transplant - Adult and Pediatric Heart/Lung Transplant High-End Imaging: Site of Care High Frequency Chest Oscillation High Intensity Focused Ultrasound (HIFU) for the treatment of localized Prostate Cancer Hip Arthroscopy HIS Bundle Study HMSA Home Care Services - General Criteria Home Care Services - Adults Home Care Services - Antepartum, Postpartum and Newborn Home Care Services - Pediatric Services Home INR Monitoring Home Narrowband UVB Phototherapy for Psoriasis Home Oxygen Therapy for Chronic Use H-Wave Stimulation Device Hyperbaric Oxygen Hyperthermia for Treatment of Cancer Hysterectomy Surgical Services Implants - Cochlear Implants - Deep Brain Stimulator Implants - Deep Brain Stimulator for Primary Headache Implants - Infusion Pumps Implants - Occipital Nerve Stimulation (ONS) for Primary Headache Implants - Vagus Nerve Stimulator Implantable Loop Recorder Implantable Pulmonary Artery Pressure Monitoring Device for Patients with Heart Failure IMT (Carotid Intima Media Thickness for Coronary Artery Disease Screening and Monitoring) Infliximab Antibodies InFUSE TM Bone Graft Inhaled Nitric Oxide Therapy Injectable Bulking Agents for Fecal Incontinence Injectable Poly-L-Lactic Acid (PLA) for Facial Lipoatrophy (Sculptura) Injection of Spinal Canal Injection - Tendon, Ligament, Ganglion Cyst, Tunnel Syndromes and Morton's Neuroma Injection - Trigger PointPayerPolicy · KAISER_WA-GENICULAR-NERVE-ABLATION-GERD-BULKING-MATERIAL-CR-BARD-S-SUTURING-SYSTEM-AND-STRETTA-PROCEDURE-GERD-LINX-REFLUX-MANAGEME | Codes changed |
|---|
| Aug 22, 2026 | Kaiser Permanente Washington | Durable Medical Equipment - Baclofen PumpPayerPolicy · KAISER_WA-DURABLE-MEDICAL-EQUIPMENT-BACLOFEN-PUMP | Codes changed |
|---|
| Aug 22, 2026 | Kaiser Permanente Washington | Baclofen PumpPayerPolicy · KAISER_WA-BACLOFEN-PUMP | Codes changed |
|---|
| Aug 22, 2026 | Independence Blue Cross | Rituximab (Rituxan) Infusion and Related Biosimilars, and Rituximab/Hyaluronidase Human for Subcutaneous Injection (Rituxan Hycela)PayerPolicy · IBX-MA-PPO-HOST-MA08-022 | Codes changed |
|---|
| Aug 22, 2026 | Independence Blue Cross | Octreotide Acetate (Sandostatin LAR Depot)PayerPolicy · IBX-MA-PPO-HOST-MA08-065 | Codes changed |
|---|
| Aug 22, 2026 | Independence Blue Cross | Zenocutuzumab-zbco (Bizengri)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-183 | Codes changed |
|---|
| Aug 22, 2026 | Independence Blue Cross | Zanidatamab-hrii (Ziihera)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-182 | Codes changed |
|---|
| Aug 22, 2026 | Independence Blue Cross | Velmanase alfa (Lamzede)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-147 | Codes changed |
|---|
| Aug 22, 2026 | Independence Blue Cross | Vedolizumab (Entyvio) for Injection for Intravenous UsePayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-001 | Codes changed |
|---|
| Aug 22, 2026 | Independence Blue Cross | Ustekinumab for Intravenous InfusionPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-042 | Codes changed |
|---|
| Aug 22, 2026 | Independence Blue Cross | Ublituximab-xiiy (Briumvi ) for intravenous usePayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-160 | Codes changed |
|---|
| Aug 22, 2026 | Independence Blue Cross | Trilaciclib (Cosela)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-134 | Codes changed |
|---|
| Aug 22, 2026 | Independence Blue Cross | Triamcinolone Acetonide ER Injectable (Zilretta)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-097 | Codes changed |
|---|
| Aug 22, 2026 | Independence Blue Cross | Trastuzumab (Herceptin) and Related Biosimilars, Trastuzumab and Hyaluronidase-oysk (Herceptin Hylecta)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-018 | Codes changed |
|---|
| Aug 22, 2026 | Independence Blue Cross | Toripalimab-tpzi (Loqtorzi)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-170 | Codes changed |
|---|
| Aug 22, 2026 | Independence Blue Cross | Tisotumab vedotin-tftv (Tivdak)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-141 | Codes changed |
|---|
| Aug 22, 2026 | Independence Blue Cross | Tislelizumab-jsgr (Tevimbra)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-173 | Codes changed |
|---|
| Aug 22, 2026 | Independence Blue Cross | Tildrakizumab-asmn (Ilumya)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-098 | Codes changed |
|---|
| Aug 22, 2026 | Independence Blue Cross | Tezepelumab-ekko (Tezspire)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-144 | Codes changed |
|---|
| Aug 22, 2026 | Independence Blue Cross | Teprotumumab (Tepezza)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-115 | Codes changed |
|---|
| Aug 22, 2026 | Independence Blue Cross | Teplizumab-mzwv (Tzield)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-157 | Codes changed |
|---|
| Aug 22, 2026 | Independence Blue Cross | Telisotuzumab vedotin-tllv (Emrelis)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-040 | Codes changed |
|---|
| Aug 22, 2026 | Independence Blue Cross | Teclistamab-cqyv (Tecvayli)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-156 | Codes changed |
|---|
| Aug 22, 2026 | Independence Blue Cross | Tebentafusp-tebn (Kimmtrak)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-143 | Codes changed |
|---|
| Aug 22, 2026 | Independence Blue Cross | Tarlatamab-dlle (Imdelltra for intravenous usePayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-176 | Codes changed |
|---|
| Aug 22, 2026 | Independence Blue Cross | Talquetamab-tgvs (Talvey)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-166 | Codes changed |
|---|
| Aug 22, 2026 | Independence Blue Cross | Tafasitamab-cxix (Monjuvi)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-138 | Codes changed |
|---|
| Aug 22, 2026 | Independence Blue Cross | Sutimlimab-jome (Enjaymo)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-145 | Codes changed |
|---|
| Aug 22, 2026 | Independence Blue Cross | Spesolimab-sbzo (Spevigo)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-155 | Codes changed |
|---|
| Aug 22, 2026 | Independence Blue Cross | Secukinumab (Cosentyx) for Intravenous UsePayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-174 | Codes changed |
|---|
| Aug 22, 2026 | Independence Blue Cross | Sacituzumab govitecan-hziy (Trodelvy)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-118 | Codes changed |
|---|
| Aug 22, 2026 | Independence Blue Cross | Rozanolixizumab-noli (Rystiggo)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-164 | Codes changed |
|---|
| Aug 22, 2026 | Independence Blue Cross | Rituximab (Rituxan) Infusion and Related Biosimilars, and Rituximab/Hyaluronidase Human for Subcutaneous Injection (Rituxan Hycela)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-022 | Codes changed |
|---|
| Aug 22, 2026 | Independence Blue Cross | Risankizumab-rzaa (Skyrizi) for intravenous usePayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-153 | Codes changed |
|---|
| Aug 22, 2026 | Independence Blue Cross | Ramucirumab (Cyramza)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-075 | Codes changed |
|---|
| Aug 22, 2026 | Independence Blue Cross | Programmed Death Receptor-1 (PD-1) Antagonists (e.g., Keytruda, Opdivo) and Programmed Death-Ligand 1 (PD-L1) Antagonists (e.g., Tecentriq, Bavencio, Imfinzi)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-010 | Codes changed |
|---|
| Aug 22, 2026 | Independence Blue Cross | Polatuzumab vedotin-piiq (Polivy)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-108 | Codes changed |
|---|
| Aug 22, 2026 | Independence Blue Cross | Photodynamic Therapy Using Verteporfin (Visudyne)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA07-003 | Codes changed |
|---|
| Aug 22, 2026 | Independence Blue Cross | Photodynamic Therapy (PDT) Using Levulan Kerastick or Ameluz (Aminolevulinic Acid HCl [ALA])PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA07-056 | Codes changed |
|---|
| Aug 22, 2026 | Independence Blue Cross | Pharmacogenetics and Metabolite Monitoring for Using Azathioprine (AZA)/6-Mercaptopurine (6-MP) TherapyPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA06-014 | Codes changed |
|---|
| Aug 22, 2026 | Independence Blue Cross | Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf (Phesgo)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-129 | Codes changed |
|---|
| Aug 22, 2026 | Independence Blue Cross | Pertuzumab (Perjeta) and related biosimilar pertuzumab-dpzb (Poherdy)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-063 | Codes changed |
|---|
| Aug 22, 2026 | Independence Blue Cross | Personalized Vaccines (e.g., Provenge)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-053 | Codes changed |
|---|
| Aug 22, 2026 | Independence Blue Cross | Pemetrexed (Pemfexy)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-047 | Codes changed |
|---|
| Aug 22, 2026 | Independence Blue Cross | Pembrolizumab and berahyaluronidase alfa-pmph (KEYTRUDA QLEX)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-189 | Codes changed |
|---|
| Aug 22, 2026 | Independence Blue Cross | Pembrolizumab (Keytruda)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-121 | Codes changed |
|---|